B

BBTX

BBTX

UnknownUnknown

Company information not available. Track real-time insider trading activity, SEC Form 4 filings, and executive stock transactions.

Insider Sentiment
Based on recent trading activity
100%Bullish
Buy/Sell Ratio100% buys
BearishBullish
BBTX Live QuoteReal-time
$15.55
+$0.56(+3.74%)1M
Day Range$15.27 – $16.43
Open$15.98
Previous Close$15.90
Volume151.5K
Key Financials & Valuation
Fundamental balance sheet & market metrics
HEALTHCARE
Market Cap$809.99M
P/E Ratio (TTM)24.5
Forward P/ENaN
EPS (TTM)$-1.73
Price to BookNaN
Dividend Yield0.65%
Beta (Volatility)1.18
IndustryBIOTECHNOLOGY
52-Week RangeCurrent: $15.55 (48%)
Low: $13.60High: $17.65
Wall Street Consensus
Buy
Analyst Rating
4.1/ 5.0
Target Price
$172.50+15.0% upside

Insider Buys

1

$46.64M

Insider Sales

0

$0

Total Volume

$46.64M

1 transactions

Net Activity

+$46.64M

Net buying

Proprietary Ratings
Calculated from Form 4 transactions
80CONFIDENCE

Sentiment Rating

Strong Accumulation

CEO Conviction Index

No Recent Signal

Key Drivers

  • •Strong buying bias: purchases represent 100% of total transaction value.
  • •Ultra-high accumulation: total purchase value exceeds $10M.
Score Methodology

The Insider Confidence Score (1-100) measures executive conviction. Starting from a neutral 50, it adjusts based on:

  • +15Strong Buy Ratio: Purchases > 70% of volume (or up to -15 for heavy sales).
  • +20Cluster Buying: ≥3 unique insiders buying within a 30-day window.
  • +15CEO Buying: CEO committing own capital shows high conviction.
  • +10CFO Buying: CFO purchasing shares shows financial alignment.
Top Insiders
Most active traders
R
1

Ra Capital Management, L.P.

Dir, 10%

1 buys0 sells

$46.64M total

Trading History
BBTX insider transactions from SEC Form 4 filings
DateInsiderTypeSharesPriceValueFiling

Oct 30, 2026

3 weeks ago

Ra Capital Management, L.P.

Dir, 10%

Director
Buy2.95M$15.79$46.64M
Sector & Industry Benchmarks
Unknown Comparison Overview
Industry Buy Conviction6%
BBTX Buy Conviction100%
Industry Rank#39 of 569
Volume Contribution0.3%
Total Industry Activity$16.53B

BBTX has an insider buy conviction of 100%, compared to the Unknown sector buy average of 6%. BBTX ranks #39 in insider activity out of 569 tracked companies in its industry.

Insider Trading Summary & Commentary
Automated executive transaction analysis for BBTX

Over the last 90 days, corporate insiders at BBTX (BBTX) engaged in a total of 1 transactions reported via SEC Form 4 filings. Among these, 1 were open-market purchases and 0 were sales. The total volume of insider trading reached $46.64M.

The net insider activity for BBTX shows a net buying bias of $46.64M. This activity represents a 100% buy ratio, suggesting that insiders are currently strongly bullish on the company's near-term outlook relative to recent history.

The most notable individual transaction was a Purchase by Ra Capital Management, L.P. (Dir, 10%), who traded 2.95M shares valued at $46.64M on Oct 30, 2026.

Live Market News & Developments
Aggregated real-time headlines for BBTX (BBTX)
6 updates

Bambusa Therapeutics: BBTX Stock Price Quote & News

Robinhood21d ago

BBTX interactive stock chart | Bambusa Therapeutics, Inc. stock

Yahoo Finance UKYesterday

symbol__ Stock Quote Price and Forecast

CNN23d ago

Bambusa Therapeutics Ord Shs (BBTX) Earnings Date & Reports & Earnings News

TradingKeyYesterday

Bambusa Therapeutics prices upsized initial public offering on Nasdaq

Vietnam Investment Review - VIR18d ago

Bispecific biotech Bambusa and Parkinson’s-focused Aspen slide on trading debuts

Seeking Alpha21d ago

FAQs About BBTX Insider Trading

Answers to common questions regarding corporate filings and executive sentiment for BBTX.

Based on SEC Form 4 disclosures, the Insider Confidence Score for BBTX is currently 80/100, which reflects a strong accumulation bias. This calculation accounts for a total of 1 purchases and 0 sales by company executives over the last 90 days.

The CEO Conviction Index for BBTX is rated as "No Recent Signal". Executive buying is typically a strong vote of confidence as C-level leaders have the most intimate knowledge of their firm's prospects. Officer selling, on the other hand, is often routine and does not automatically signal operational weakness.

No. Insider tracking is a highly informative technical signal that indicates executive sentiment, but it should not be the sole basis for a transaction. Investors should combine this filing analysis with company financials, sector trends, and risk management criteria.